{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:58:40Z","timestamp":1793314720435,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370521"],"award-info":[{"award-number":["82370521"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","award":["2024QH2040"],"award-info":[{"award-number":["2024QH2040"]}],"id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115421","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T09:32:58Z","timestamp":1756200778000},"page":"115421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Intratumoral microbiota-driven macrophage reprogramming in pancreatic cancer via Blautia metabolite 6-hydroxyhexanoic acid"],"prefix":"10.1016","volume":"164","author":[{"given":"Yun","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangeng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2025.115421_bb0005","first-page":"271","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.intimp.2025.115421_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2025.115421_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1287459","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Hartupee","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115421_bb0020","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","article-title":"Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer","volume":"32","author":"Wang","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"7681","key":"10.1016\/j.intimp.2025.115421_bb0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2025.115421_bb0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115421_bb0045","article-title":"Research progress on the impact of intratumoral microbiota on the immune microenvironment of malignant tumors and its role in immunotherapy","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115421_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1456030","article-title":"Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","article-title":"The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases","volume":"13","author":"Hosseinkhani","year":"2021","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.intimp.2025.115421_bb0060","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cels.2024.11.010","article-title":"Metabolic immunoengineering approaches to enhance CD8(+) T cell-based cancer immunotherapy","volume":"15","author":"Feng","year":"2024","journal-title":"Cell Syst."},{"key":"10.1016\/j.intimp.2025.115421_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12672-024-01256-x","article-title":"The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets","volume":"15","author":"Lorestani","year":"2024","journal-title":"Discov. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115421_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2276314","article-title":"Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment","volume":"15","author":"Zhou","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.intimp.2025.115421_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115276","article-title":"The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: mechanisms and therapeutic potentials","volume":"165","author":"Duan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115421_bb0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.niox.2020.04.005","article-title":"Isolation and culture of murine bone marrow-derived macrophages for nitric oxide and redox biology","volume":"100\u2013101","author":"Bailey","year":"2020","journal-title":"Nitric Oxide"},{"issue":"28","key":"10.1016\/j.intimp.2025.115421_bb0090","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.3748\/wjg.v20.i28.9476","article-title":"Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel","volume":"20","author":"Jiang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nprot.2014.197","article-title":"Synthesis of fluorescent D-amino acids and their use for probing peptidoglycan synthesis and bacterial growth in situ","volume":"10","author":"Kuru","year":"2015","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.intimp.2025.115421_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00962-24","article-title":"Integrated analysis of microbiome and metabolome reveals signatures in PDAC tumorigenesis and prognosis","volume":"12","author":"Fang","year":"2024","journal-title":"Microbiol. Spectr."},{"issue":"15","key":"10.1016\/j.intimp.2025.115421_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells13151279","article-title":"Intratumoral microbiome: foe or friend in reshaping the tumor microenvironment landscape?","volume":"13","author":"Kyriazi","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.intimp.2025.115421_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/imm.12917","article-title":"Hypoxia and acidosis: immune suppressors and therapeutic targets","volume":"154","author":"Damgaci","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2025.115421_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.673724","article-title":"The interaction between the microbiome and tumors","volume":"11","author":"Zong","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"16","key":"10.1016\/j.intimp.2025.115421_bb0120","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1128\/AEM.01235-16","article-title":"The microbiota of breast tissue and its association with breast cancer","volume":"82","author":"Urbaniak","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","article-title":"Blautia-a new functional genus with potential probiotic properties?","volume":"13","author":"Liu","year":"2021","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.intimp.2025.115421_bb0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.intimp.2025.115421_bb0135","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-16-1765","article-title":"Human pancreatic cancer cells induce a MyD88-dependent stromal response to promote a tumor-tolerant immune microenvironment","volume":"77","author":"Delitto","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0140","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1186\/s12967-024-05762-y","article-title":"Blautia coccoides and its metabolic products enhance the efficacy of bladder cancer immunotherapy by promoting CD8(+) T cell infiltration","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115421_bb0145","article-title":"Global analysis of microbiota signatures in four major types of gastrointestinal cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0150","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5661","article-title":"Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)","volume":"65","author":"Zhou","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2025.115421_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115421_bb0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.intimp.2025.115421_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.intimp.2025.115421_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2025.115421_bb0185","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1074\/jbc.M112.420042","article-title":"Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor","volume":"288","author":"Suzuki","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2025.115421_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166487","article-title":"Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2025.115421_bb0195","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.intimp.2025.115421_bb0200","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.intimp.2025.115421_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.5009\/gnl210311","article-title":"CD40 agonists alter the pancreatic cancer microenvironment by shifting the macrophage phenotype toward M1 and suppress human pancreatic cancer in organotypic slice cultures","volume":"16","author":"Lim","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.intimp.2025.115421_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115421_bb0215","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12026-021-09209-0","article-title":"TLR4 and TNFR1 blockade dampen M1 macrophage activation and shifts them towards an M2 phenotype","volume":"69","author":"Sawoo","year":"2021","journal-title":"Immunol. Res."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2025.115421_bb0220","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.imbio.2010.05.031","article-title":"Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming","volume":"215","author":"El Chartouni","year":"2010","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.intimp.2025.115421_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115421_bb0230","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/s41587-023-01676-0","article-title":"High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq","volume":"41","author":"Liu","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2025.115421_bb0235","first-page":"605493","article-title":"Spatial dynamics of mammalian brain development and neuroinflammation by multimodal tri-omics mapping","volume":"7","author":"Zhang","year":"2024","journal-title":"bioRxiv."},{"key":"10.1016\/j.intimp.2025.115421_bb0240","first-page":"624106","article-title":"Spatially Resolved in vivo CRISPR Screen Sequencing via Perturb-DBiT","volume":"11","author":"Baysoy","year":"2024","journal-title":"bioRxiv."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925014122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:49:44Z","timestamp":1772891384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925014122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":48,"alternative-id":["S1567576925014122"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115421","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratumoral microbiota-driven macrophage reprogramming in pancreatic cancer via Blautia metabolite 6-hydroxyhexanoic acid","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115421"}}